Tom ntej: Semaglutide Acetate CAS 1997361-85-9

Xa kev nug
Tom ntej: Semaglutide Acetate CAS 1997361-85-9
Paub meej
CAS: 1997361-85-9 Nr
Ib ntus: His-Aib-Glu-Gly-Thr-Ph-Thr-Ser-Asp-Val-Ser{-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18 diacid- -Glu-(AEEA)₂)-Glu-Ph-Ile-Ala-Trp-Leu-Val{{29}{Arg-Gly
Peb kuj muab kev qhia tshwj xeeb los ntawm crude mus rau 99% purity. thov hu rau peb kom paub meej!

Cov ntaub ntawv ntsig txog
COA/MS/HPLC Report
Peptide Dissolution thiab Cia Phau Ntawv Qhia
Qeb
Pharmaceutical Peptides
Kev faib tawm yam khoom
Pharmaceutical Peptides
Share to
Hauj lwm lawm

Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas 1997361-85-9 semaglutide acetate hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas 1997361-85-9 semaglutide acetate los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

Khoom npe Tom ntej: Semaglutide Acetate CAS 1997361-85-9
Ib ntus His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18 diacid--Glu-(AEEA)₂)-Glu-Phe-Ile-Ala-Trp-Le-Ar
Peb tsab ntawv ib ntus H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(C18 diacid- -Glu-(AEEA)₂)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
Peptide purity (HPLC, %) 95%/98%/99%
Cov mis mos molecular C₁₈₉H₂₉₅N₄₅O₆₁
Molecular Luj (Da) 4173.69

 

Product Basic Information Table

 

Khoom Lub Npe Lus Askiv Product Abbreviation / Alias Function Tags (comma-sib cais) Amino Acid Tag Nrho Lub Npe Sequence Molecular Formula Qhov hnyav Molecular (Da) Qhov Nruab Nrab Molecular Luj (Da) Terminal Hloov kho - N-terminus Terminal Hloov kho - C-terminus Qhov ntev (aa)
Semaglutide acetate hmoov Semaglutide acetate; CAS 1997361-85-9 (dawb puag); Kev ua haujlwm ntev GLP-1 analog GLP-1 receptor agonist, Ntev - ua haujlwm tiv thaiv - ntshav qab zib peptide, Kev tiv thaiv kev rog, kev noj qab haus huv, kev tshawb fawb txog metabolic, GPCR cov cuab yeej peptide Histidine-2-aminoisobutyric acid-Glutamic acid-Glycine-Threonine-Phenylalanine-Threonine-Serine-Aspartic acid-Valine-Serine-Serine-Tyrosine-Leucine-Glutamic acid-Glycine-Glutamine-Alanine-Alanine{2{2} diacid- -Glutamic acid-(AEEA)₂]-Glutamic acid-Phenylalanine-Isoleucine-Alanine-Tryptophan-Leucine-Valine-Arginine-Glycine-Arginine-Glycine C₁₈₉H₂₉₅N₄₅O₆₁ (monoacetate) 4170.18 4173.69 Dawb amine, unmodified Dawb carboxyl, unmodified 31

 

Physicochemical Solubility & Cia Parameters

 

Khoom Code Qhov tshwm sim Ntev - Lub Sij Hawm Cia Cov Cai Luv -Lub Sijhawm Cia Cov Cai Kua Stability Khoom hmoov ruaj khov
PEB-SEMA001 Dawb hmoov Khaws ntawm -20 degree, tiv thaiv lub teeb, kaw thiab qhuav, aliquoted; zam rov qab khov-thaw cycles thiab ya raws Khoom hmoov ruaj khov rau 2 xyoos kaw thiab qhuav ntawm 2-8 degree; npaj aqueous daws freshly ua ntej siv, aliquots ruaj khov rau 1 lub hlis ntawm -20 degree; 0.1% BSA raug pom zoo kom ncua kev ruaj ntseg ruaj khov rau 72 h ntawm 4 degree; zam rov qab khov -thaw cycles ruaj khov rau 3 xyoos ntawm -20℃nyob rau hauv qhuav & tsaus ntuj

 

Functional Description

 

Khoom Code Frontend Short Summary (rau cov npe tshawb nrhiav) Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg Cov cheeb tsam tshawb fawb (comma- cais) Hom phiaj / Receptor
PEB-SEMA001 Ntev- ua yeeb yam xaiv GLP-1 receptor agonist; Glucose-dependent glycemic tswj, qab los noj mov, kev noj zaub mov qeeb qeeb, poob phaus thiab cov txiaj ntsig cardiometabolic Semaglutide acetate yog qhov ntev - ua yeeb yam hloov pauv ntawm tib neeg glucagon-zoo li peptide-1 (GLP-1). Nws qhia tau hais tias muaj kev xaiv siab rau GLP-1 receptors uas tsis muaj kev cuam tshuam tseem ceeb rau GIP lossis glucagon receptors. Kev hloov pauv Aib ntawm txoj haujlwm 2 muab qhov zoo tshaj plaws tiv thaiv rau dipeptidyl peptidase-4 (DPP-4) proteolysis. A C18 fatty diacid sab saw yog covalently conjugated rau ε-amino pab pawg ntawm Lys20, ua rau reversible serum albumin binding thiab ntev heev nyob rau hauv vivo ib nrab-lub neej, muab cov qauv hauv paus rau kev tsim qauv ntev. Nws txhawb kev tsim cov tshuaj insulin thiab txo qis glucagon tso tawm hauv cov piam thaj-dependant kom ruaj khov glycemic hloov pauv. Nws kuj tseem ncua lub plab zom mov thiab txo qhov qab los noj mov hauv nruab nrab kom txo tau cov zaub mov kom tsawg thiab ua kom poob phaus. Tsis tas li ntawd, nws nthuav tawm cov dej num suav nrog kev txhim kho lipid profile, txo qis vascular o thiab ameliorated hepatic lipid metabolism kom qeeb MASLD kev loj hlob. Nws yog dav siv rau kev tshawb fawb pharmacological thiab tshiab peptide tshuaj txhim kho lub hom phiaj hom 2 mob ntshav qab zib, rog rog, metabolic txuam nrog kab mob siab thiab kev tiv thaiv kab mob plawv. Diabetes pharmacology tshawb fawb, Kev rog rog thiab kev tshawb nrhiav kab mob metabolic, Tshuaj tiv thaiv - mob ntshav qab zib peptide tshuaj txhim kho, MASLD kev tshawb fawb, Kev tshawb fawb tshuaj mob plawv, GPCR qhia txoj kev tshawb fawb Glucagon-zoo li peptide-1 receptor (GLP-1R); cAMP/PKA teeb liab txoj kev

Cim npe nrov: CAS 1997361-85-9 semaglutide acetate, Tuam Tshoj cas 1997361-85-9 semaglutide acetate manufacturers, lwm tus neeg, Hoobkas

Xa kev nug